# Clinical Study to Evaluate Tolerability and Safety of FXFM244 and to Monitor Clinical Effect in Acne Vulgaris Patients

> **NCT01362010** · PHASE2 · COMPLETED · sponsor: **Vyne Therapeutics Inc.** · enrollment: 150 (actual)

## Conditions studied

- Acne Vulgaris

## Interventions

- **DRUG:** Topical Minocycline Foam FXFM244

## Key facts

- **NCT ID:** NCT01362010
- **Lead sponsor:** Vyne Therapeutics Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-01
- **Primary completion:** 2013-06
- **Final completion:** 2013-07
- **Target enrollment:** 150 (ACTUAL)
- **Last updated:** 2013-08-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01362010

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01362010, "Clinical Study to Evaluate Tolerability and Safety of FXFM244 and to Monitor Clinical Effect in Acne Vulgaris Patients". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01362010. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*